The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sorafenib Tosylate API Market Research Report 2025
Synopsis
The global market for Sorafenib Tosylate API was valued at US$ 40 million in the year 2024 and is projected to reach a revised size of US$ 59 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sorafenib Tosylate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib Tosylate API.
The Sorafenib Tosylate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib Tosylate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sorafenib Tosylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva API
Natco Pharma
Cipla
Alembic Pharmaceutical
Hetero
Aurobindo Pharma
Sun Pharmaceutical Industries
BDR Lifesciences
Delmar Chemicals
Yabao Pharmaceutical Group
Sichuan Xieli Pharmaceutical
by Type
FormⅠ
Form Ⅲ
by Application
Pharmaceutical
Scientific Research
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sorafenib Tosylate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sorafenib Tosylate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sorafenib Tosylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Sorafenib Tosylate API was valued at US$ 40 million in the year 2024 and is projected to reach a revised size of US$ 59 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sorafenib Tosylate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib Tosylate API.
The Sorafenib Tosylate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib Tosylate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sorafenib Tosylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva API
Natco Pharma
Cipla
Alembic Pharmaceutical
Hetero
Aurobindo Pharma
Sun Pharmaceutical Industries
BDR Lifesciences
Delmar Chemicals
Yabao Pharmaceutical Group
Sichuan Xieli Pharmaceutical
by Type
FormⅠ
Form Ⅲ
by Application
Pharmaceutical
Scientific Research
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sorafenib Tosylate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sorafenib Tosylate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sorafenib Tosylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Sorafenib Tosylate API Market Overview
1.1 Product Definition
1.2 Sorafenib Tosylate API by Type
1.2.1 Global Sorafenib Tosylate API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 FormⅠ
1.2.3 Form Ⅲ
1.3 Sorafenib Tosylate API by Application
1.3.1 Global Sorafenib Tosylate API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Sorafenib Tosylate API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Sorafenib Tosylate API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Sorafenib Tosylate API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Sorafenib Tosylate API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sorafenib Tosylate API Production Market Share by Manufacturers (2020-2025)
2.2 Global Sorafenib Tosylate API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Sorafenib Tosylate API, Industry Ranking, 2023 VS 2024
2.4 Global Sorafenib Tosylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Sorafenib Tosylate API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Sorafenib Tosylate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Sorafenib Tosylate API, Product Offered and Application
2.8 Global Key Manufacturers of Sorafenib Tosylate API, Date of Enter into This Industry
2.9 Sorafenib Tosylate API Market Competitive Situation and Trends
2.9.1 Sorafenib Tosylate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Sorafenib Tosylate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Sorafenib Tosylate API Production by Region
3.1 Global Sorafenib Tosylate API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Sorafenib Tosylate API Production Value by Region (2020-2031)
3.2.1 Global Sorafenib Tosylate API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Sorafenib Tosylate API by Region (2026-2031)
3.3 Global Sorafenib Tosylate API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Sorafenib Tosylate API Production Volume by Region (2020-2031)
3.4.1 Global Sorafenib Tosylate API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Sorafenib Tosylate API by Region (2026-2031)
3.5 Global Sorafenib Tosylate API Market Price Analysis by Region (2020-2025)
3.6 Global Sorafenib Tosylate API Production and Value, Year-over-Year Growth
3.6.1 North America Sorafenib Tosylate API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Sorafenib Tosylate API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Sorafenib Tosylate API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Sorafenib Tosylate API Production Value Estimates and Forecasts (2020-2031)
4 Sorafenib Tosylate API Consumption by Region
4.1 Global Sorafenib Tosylate API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Sorafenib Tosylate API Consumption by Region (2020-2031)
4.2.1 Global Sorafenib Tosylate API Consumption by Region (2020-2025)
4.2.2 Global Sorafenib Tosylate API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Sorafenib Tosylate API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Sorafenib Tosylate API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Sorafenib Tosylate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Sorafenib Tosylate API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Sorafenib Tosylate API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Sorafenib Tosylate API Production by Type (2020-2031)
5.1.1 Global Sorafenib Tosylate API Production by Type (2020-2025)
5.1.2 Global Sorafenib Tosylate API Production by Type (2026-2031)
5.1.3 Global Sorafenib Tosylate API Production Market Share by Type (2020-2031)
5.2 Global Sorafenib Tosylate API Production Value by Type (2020-2031)
5.2.1 Global Sorafenib Tosylate API Production Value by Type (2020-2025)
5.2.2 Global Sorafenib Tosylate API Production Value by Type (2026-2031)
5.2.3 Global Sorafenib Tosylate API Production Value Market Share by Type (2020-2031)
5.3 Global Sorafenib Tosylate API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Sorafenib Tosylate API Production by Application (2020-2031)
6.1.1 Global Sorafenib Tosylate API Production by Application (2020-2025)
6.1.2 Global Sorafenib Tosylate API Production by Application (2026-2031)
6.1.3 Global Sorafenib Tosylate API Production Market Share by Application (2020-2031)
6.2 Global Sorafenib Tosylate API Production Value by Application (2020-2031)
6.2.1 Global Sorafenib Tosylate API Production Value by Application (2020-2025)
6.2.2 Global Sorafenib Tosylate API Production Value by Application (2026-2031)
6.2.3 Global Sorafenib Tosylate API Production Value Market Share by Application (2020-2031)
6.3 Global Sorafenib Tosylate API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Teva API
7.1.1 Teva API Sorafenib Tosylate API Company Information
7.1.2 Teva API Sorafenib Tosylate API Product Portfolio
7.1.3 Teva API Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Teva API Main Business and Markets Served
7.1.5 Teva API Recent Developments/Updates
7.2 Natco Pharma
7.2.1 Natco Pharma Sorafenib Tosylate API Company Information
7.2.2 Natco Pharma Sorafenib Tosylate API Product Portfolio
7.2.3 Natco Pharma Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Natco Pharma Main Business and Markets Served
7.2.5 Natco Pharma Recent Developments/Updates
7.3 Cipla
7.3.1 Cipla Sorafenib Tosylate API Company Information
7.3.2 Cipla Sorafenib Tosylate API Product Portfolio
7.3.3 Cipla Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Cipla Main Business and Markets Served
7.3.5 Cipla Recent Developments/Updates
7.4 Alembic Pharmaceutical
7.4.1 Alembic Pharmaceutical Sorafenib Tosylate API Company Information
7.4.2 Alembic Pharmaceutical Sorafenib Tosylate API Product Portfolio
7.4.3 Alembic Pharmaceutical Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Alembic Pharmaceutical Main Business and Markets Served
7.4.5 Alembic Pharmaceutical Recent Developments/Updates
7.5 Hetero
7.5.1 Hetero Sorafenib Tosylate API Company Information
7.5.2 Hetero Sorafenib Tosylate API Product Portfolio
7.5.3 Hetero Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Hetero Main Business and Markets Served
7.5.5 Hetero Recent Developments/Updates
7.6 Aurobindo Pharma
7.6.1 Aurobindo Pharma Sorafenib Tosylate API Company Information
7.6.2 Aurobindo Pharma Sorafenib Tosylate API Product Portfolio
7.6.3 Aurobindo Pharma Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Aurobindo Pharma Main Business and Markets Served
7.6.5 Aurobindo Pharma Recent Developments/Updates
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Sorafenib Tosylate API Company Information
7.7.2 Sun Pharmaceutical Industries Sorafenib Tosylate API Product Portfolio
7.7.3 Sun Pharmaceutical Industries Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Sun Pharmaceutical Industries Main Business and Markets Served
7.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.8 BDR Lifesciences
7.8.1 BDR Lifesciences Sorafenib Tosylate API Company Information
7.8.2 BDR Lifesciences Sorafenib Tosylate API Product Portfolio
7.8.3 BDR Lifesciences Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 BDR Lifesciences Main Business and Markets Served
7.8.5 BDR Lifesciences Recent Developments/Updates
7.9 Delmar Chemicals
7.9.1 Delmar Chemicals Sorafenib Tosylate API Company Information
7.9.2 Delmar Chemicals Sorafenib Tosylate API Product Portfolio
7.9.3 Delmar Chemicals Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Delmar Chemicals Main Business and Markets Served
7.9.5 Delmar Chemicals Recent Developments/Updates
7.10 Yabao Pharmaceutical Group
7.10.1 Yabao Pharmaceutical Group Sorafenib Tosylate API Company Information
7.10.2 Yabao Pharmaceutical Group Sorafenib Tosylate API Product Portfolio
7.10.3 Yabao Pharmaceutical Group Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Yabao Pharmaceutical Group Main Business and Markets Served
7.10.5 Yabao Pharmaceutical Group Recent Developments/Updates
7.11 Sichuan Xieli Pharmaceutical
7.11.1 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Company Information
7.11.2 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product Portfolio
7.11.3 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Sichuan Xieli Pharmaceutical Main Business and Markets Served
7.11.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sorafenib Tosylate API Industry Chain Analysis
8.2 Sorafenib Tosylate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sorafenib Tosylate API Production Mode & Process Analysis
8.4 Sorafenib Tosylate API Sales and Marketing
8.4.1 Sorafenib Tosylate API Sales Channels
8.4.2 Sorafenib Tosylate API Distributors
8.5 Sorafenib Tosylate API Customer Analysis
9 Sorafenib Tosylate API Market Dynamics
9.1 Sorafenib Tosylate API Industry Trends
9.2 Sorafenib Tosylate API Market Drivers
9.3 Sorafenib Tosylate API Market Challenges
9.4 Sorafenib Tosylate API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sorafenib Tosylate API Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Sorafenib Tosylate API Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Sorafenib Tosylate API Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Sorafenib Tosylate API Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Sorafenib Tosylate API Production Market Share by Manufacturers (2020-2025)
Table 6. Global Sorafenib Tosylate API Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Sorafenib Tosylate API Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Sorafenib Tosylate API, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Sorafenib Tosylate API as of 2024)
Table 10. Global Market Sorafenib Tosylate API Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Sorafenib Tosylate API, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Sorafenib Tosylate API, Product Offered and Application
Table 13. Global Key Manufacturers of Sorafenib Tosylate API, Date of Enter into This Industry
Table 14. Global Sorafenib Tosylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sorafenib Tosylate API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Sorafenib Tosylate API Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Sorafenib Tosylate API Production Value Market Share by Region (2020-2025)
Table 19. Global Sorafenib Tosylate API Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Sorafenib Tosylate API Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Sorafenib Tosylate API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Sorafenib Tosylate API Production (Tons) by Region (2020-2025)
Table 23. Global Sorafenib Tosylate API Production Market Share by Region (2020-2025)
Table 24. Global Sorafenib Tosylate API Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Sorafenib Tosylate API Production Market Share Forecast by Region (2026-2031)
Table 26. Global Sorafenib Tosylate API Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Sorafenib Tosylate API Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Sorafenib Tosylate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Sorafenib Tosylate API Consumption by Region (2020-2025) & (Tons)
Table 30. Global Sorafenib Tosylate API Consumption Market Share by Region (2020-2025)
Table 31. Global Sorafenib Tosylate API Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Sorafenib Tosylate API Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Sorafenib Tosylate API Consumption by Country (2020-2025) & (Tons)
Table 35. North America Sorafenib Tosylate API Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Sorafenib Tosylate API Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Sorafenib Tosylate API Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Sorafenib Tosylate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Sorafenib Tosylate API Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Sorafenib Tosylate API Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Sorafenib Tosylate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Sorafenib Tosylate API Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Sorafenib Tosylate API Consumption by Country (2026-2031) & (Tons)
Table 45. Global Sorafenib Tosylate API Production (Tons) by Type (2020-2025)
Table 46. Global Sorafenib Tosylate API Production (Tons) by Type (2026-2031)
Table 47. Global Sorafenib Tosylate API Production Market Share by Type (2020-2025)
Table 48. Global Sorafenib Tosylate API Production Market Share by Type (2026-2031)
Table 49. Global Sorafenib Tosylate API Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Sorafenib Tosylate API Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Sorafenib Tosylate API Production Value Market Share by Type (2020-2025)
Table 52. Global Sorafenib Tosylate API Production Value Market Share by Type (2026-2031)
Table 53. Global Sorafenib Tosylate API Price (US$/Ton) by Type (2020-2025)
Table 54. Global Sorafenib Tosylate API Price (US$/Ton) by Type (2026-2031)
Table 55. Global Sorafenib Tosylate API Production (Tons) by Application (2020-2025)
Table 56. Global Sorafenib Tosylate API Production (Tons) by Application (2026-2031)
Table 57. Global Sorafenib Tosylate API Production Market Share by Application (2020-2025)
Table 58. Global Sorafenib Tosylate API Production Market Share by Application (2026-2031)
Table 59. Global Sorafenib Tosylate API Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Sorafenib Tosylate API Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Sorafenib Tosylate API Production Value Market Share by Application (2020-2025)
Table 62. Global Sorafenib Tosylate API Production Value Market Share by Application (2026-2031)
Table 63. Global Sorafenib Tosylate API Price (US$/Ton) by Application (2020-2025)
Table 64. Global Sorafenib Tosylate API Price (US$/Ton) by Application (2026-2031)
Table 65. Teva API Sorafenib Tosylate API Company Information
Table 66. Teva API Sorafenib Tosylate API Specification and Application
Table 67. Teva API Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Teva API Main Business and Markets Served
Table 69. Teva API Recent Developments/Updates
Table 70. Natco Pharma Sorafenib Tosylate API Company Information
Table 71. Natco Pharma Sorafenib Tosylate API Specification and Application
Table 72. Natco Pharma Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Natco Pharma Main Business and Markets Served
Table 74. Natco Pharma Recent Developments/Updates
Table 75. Cipla Sorafenib Tosylate API Company Information
Table 76. Cipla Sorafenib Tosylate API Specification and Application
Table 77. Cipla Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Cipla Main Business and Markets Served
Table 79. Cipla Recent Developments/Updates
Table 80. Alembic Pharmaceutical Sorafenib Tosylate API Company Information
Table 81. Alembic Pharmaceutical Sorafenib Tosylate API Specification and Application
Table 82. Alembic Pharmaceutical Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Alembic Pharmaceutical Main Business and Markets Served
Table 84. Alembic Pharmaceutical Recent Developments/Updates
Table 85. Hetero Sorafenib Tosylate API Company Information
Table 86. Hetero Sorafenib Tosylate API Specification and Application
Table 87. Hetero Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Hetero Main Business and Markets Served
Table 89. Hetero Recent Developments/Updates
Table 90. Aurobindo Pharma Sorafenib Tosylate API Company Information
Table 91. Aurobindo Pharma Sorafenib Tosylate API Specification and Application
Table 92. Aurobindo Pharma Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Aurobindo Pharma Main Business and Markets Served
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Sorafenib Tosylate API Company Information
Table 96. Sun Pharmaceutical Industries Sorafenib Tosylate API Specification and Application
Table 97. Sun Pharmaceutical Industries Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Industries Main Business and Markets Served
Table 99. Sun Pharmaceutical Industries Recent Developments/Updates
Table 100. BDR Lifesciences Sorafenib Tosylate API Company Information
Table 101. BDR Lifesciences Sorafenib Tosylate API Specification and Application
Table 102. BDR Lifesciences Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. BDR Lifesciences Main Business and Markets Served
Table 104. BDR Lifesciences Recent Developments/Updates
Table 105. Delmar Chemicals Sorafenib Tosylate API Company Information
Table 106. Delmar Chemicals Sorafenib Tosylate API Specification and Application
Table 107. Delmar Chemicals Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Delmar Chemicals Main Business and Markets Served
Table 109. Delmar Chemicals Recent Developments/Updates
Table 110. Yabao Pharmaceutical Group Sorafenib Tosylate API Company Information
Table 111. Yabao Pharmaceutical Group Sorafenib Tosylate API Specification and Application
Table 112. Yabao Pharmaceutical Group Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Yabao Pharmaceutical Group Main Business and Markets Served
Table 114. Yabao Pharmaceutical Group Recent Developments/Updates
Table 115. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Company Information
Table 116. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Specification and Application
Table 117. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Sichuan Xieli Pharmaceutical Main Business and Markets Served
Table 119. Sichuan Xieli Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Sorafenib Tosylate API Distributors List
Table 123. Sorafenib Tosylate API Customers List
Table 124. Sorafenib Tosylate API Market Trends
Table 125. Sorafenib Tosylate API Market Drivers
Table 126. Sorafenib Tosylate API Market Challenges
Table 127. Sorafenib Tosylate API Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sorafenib Tosylate API
Figure 2. Global Sorafenib Tosylate API Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Sorafenib Tosylate API Market Share by Type: 2024 VS 2031
Figure 4. FormⅠ Product Picture
Figure 5. Form Ⅲ Product Picture
Figure 6. Global Sorafenib Tosylate API Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Sorafenib Tosylate API Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical
Figure 9. Scientific Research
Figure 10. Other
Figure 11. Global Sorafenib Tosylate API Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Sorafenib Tosylate API Production Value (US$ Million) & (2020-2031)
Figure 13. Global Sorafenib Tosylate API Production Capacity (Tons) & (2020-2031)
Figure 14. Global Sorafenib Tosylate API Production (Tons) & (2020-2031)
Figure 15. Global Sorafenib Tosylate API Average Price (US$/Ton) & (2020-2031)
Figure 16. Sorafenib Tosylate API Report Years Considered
Figure 17. Sorafenib Tosylate API Production Share by Manufacturers in 2024
Figure 18. Global Sorafenib Tosylate API Production Value Share by Manufacturers (2024)
Figure 19. Sorafenib Tosylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. The Global 5 and 10 Largest Players: Market Share by Sorafenib Tosylate API Revenue in 2024
Figure 21. Global Sorafenib Tosylate API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Sorafenib Tosylate API Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 23. Global Sorafenib Tosylate API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 24. Global Sorafenib Tosylate API Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. North America Sorafenib Tosylate API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Sorafenib Tosylate API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. China Sorafenib Tosylate API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Sorafenib Tosylate API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Global Sorafenib Tosylate API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 30. Global Sorafenib Tosylate API Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 31. North America Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 32. North America Sorafenib Tosylate API Consumption Market Share by Country (2020-2031)
Figure 33. U.S. Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 34. Canada Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Europe Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Europe Sorafenib Tosylate API Consumption Market Share by Country (2020-2031)
Figure 37. Germany Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. France Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. U.K. Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. Italy Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Russia Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Asia Pacific Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Asia Pacific Sorafenib Tosylate API Consumption Market Share by Region (2020-2031)
Figure 44. China Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. Japan Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. South Korea Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. China Taiwan Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. Southeast Asia Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. India Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. Latin America, Middle East & Africa Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Latin America, Middle East & Africa Sorafenib Tosylate API Consumption Market Share by Country (2020-2031)
Figure 52. Mexico Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Brazil Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Turkey Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. GCC Countries Sorafenib Tosylate API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. Global Production Market Share of Sorafenib Tosylate API by Type (2020-2031)
Figure 57. Global Production Value Market Share of Sorafenib Tosylate API by Type (2020-2031)
Figure 58. Global Sorafenib Tosylate API Price (US$/Ton) by Type (2020-2031)
Figure 59. Global Production Market Share of Sorafenib Tosylate API by Application (2020-2031)
Figure 60. Global Production Value Market Share of Sorafenib Tosylate API by Application (2020-2031)
Figure 61. Global Sorafenib Tosylate API Price (US$/Ton) by Application (2020-2031)
Figure 62. Sorafenib Tosylate API Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
